Pharma Capital
Showing 9 of 9
Name Market Market Cap Share Price Daily Share Movement
ahz[LOGO]200x100.jpg Admedus ASX £40.58m £0.16 3.77% ico_glass.png
cdy[LOGO]200x100.jpg Cellmid ASX £16.15m £0.02 -3.70% ico_glass.png
Cynata.png Cynata Therapeutics ASX £29.73m £0.33 0.00% ico_glass.png
Dimerix-logo-200.png Dimerix ASX £7.72m £0.00 -12.50% ico_glass.png
au_novogen__120x60.jpg Novogen ASX £12.88m £0.03 2.22% ico_glass.png
par[LOGO]200x100.jpg Paradigm Biopharmaceuticals ASX £37.33m £0.37 -0.78% ico_glass.png
Pharmaxis---200x100.jpg Pharmaxis ASX £49.90m £0.16 0.00% ico_glass.png
au_piqlogo_new120x60.jpg Proteomics International Laboratories ASX £5.64m £0.10 -2.94% ico_glass.png
rgs[LOGO]200x100.jpg Regeneus ASX £15.12m £0.07 -10.71% ico_glass.png

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.